Technology
Health
Biotechnology

Tiziana Life Sciences

$5.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.30 (-5.66%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell TLSA and other stocks, options, ETFs, and crypto commission-free!

About

Tiziana Life Sciences Plc operates as a clinical stage biotechnology company that focuses on the discovery and development of drugs that treat human disease in oncology and immunology. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.

Employees
11
Headquarters
London, Greater London
Founded
2013
Market Cap
Price-Earnings Ratio
Dividend Yield
Average Volume
2.16K
High Today
$5.00
Low Today
$5.00
Open Price
$5.00
Volume
100.00
52 Week High
$12.17
52 Week Low
$5.00

Collections

Technology
Health
Biotechnology
Medical
2018 IPO
UK
Europe

Earnings

-$0.08
-$0.07
-$0.07
-$0.06
Q4 2018
Estimated
-$0.07 per share
Actual
Expected Mar 27, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.